Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Otorhinolaryngological tissue penetration study of T-4288 (solithromycin) in patients scheduled for surgery
jRCT2080222702Phase 2
- Sponsor
- Fujifilm
- Start
- Dec 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of solithromycin in bacterial disease, sponsored by Fujifilm. Primary endpoint: Otorhinolaryngological tissue penetration of solithromycin.
02
Drugs
solithromycin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on jRCT2080222702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222702.